mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0008 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0008 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |